These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 21056739)

  • 41. Severe immunodeficiency associated with acute lymphoblastic leukemia and its treatment.
    Raje N; Snyder BL; Hill DA; Streicher JL; Sullivan KE
    Ann Allergy Asthma Immunol; 2018 May; 120(5):537-538.e1. PubMed ID: 29563054
    [No Abstract]   [Full Text] [Related]  

  • 42. Use of immunoglobulins in adults in a university hospital: a retrospective study.
    Farber CM; Van der Biest-Cardinal C
    Acta Clin Belg; 2011; 66(6):416-8. PubMed ID: 22338302
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Intravenous inmunoglobulins in pediatrics].
    Panadero Esteban MI; Carcelén Andrés J; Urbieta Sanz E; Viñuales Armengol MC; Idoipe Tomás A
    Farm Hosp; 2003; 27(3):179-87. PubMed ID: 12835820
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Prevention and therapy with immunoglobulin SRK].
    Schnoz M; Ryser DH; Barandun S; Eckmann L
    Helv Chir Acta; 1979 May; 46(1-2):111-3. PubMed ID: 38227
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Indications for intravenous immunoglobulins].
    Spertini F
    Rev Med Suisse Romande; 1993 Mar; 113(3):179-82. PubMed ID: 8480110
    [No Abstract]   [Full Text] [Related]  

  • 46. Nursing guidelines for administration of immunoglobulin replacement therapy.
    Younger ME; Aro L; Blouin W; Duff C; Epland KB; Murphy E; Sedlak D;
    J Infus Nurs; 2013; 36(1):58-68. PubMed ID: 23271153
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Therapy recommendations for the use of intravenously applicable immunoglobulins].
    Marschner JP; Rietbrock N
    Med Klin (Munich); 1996 Mar; 91(3):141-7. PubMed ID: 8628200
    [No Abstract]   [Full Text] [Related]  

  • 48. [Therapeutic indications of intravenous immunoglobulins].
    Tellier Z; Mouthon L
    Transfus Clin Biol; 2003 Jun; 10(3):179-84. PubMed ID: 12798854
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunodeficiency: updating the personalized medicine approach to diagnostics and therapeutics.
    Buckland M
    Expert Rev Clin Immunol; 2012 Mar; 8(3):223-5. PubMed ID: 22390485
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical uses of intravenous immunoglobulin.
    Jolles S; Sewell WA; Misbah SA
    Clin Exp Immunol; 2005 Oct; 142(1):1-11. PubMed ID: 16178850
    [No Abstract]   [Full Text] [Related]  

  • 51. The role of intravenous immunoglobulins in pediatric diseases.
    Ramasubramanian KV; Kumar A; Kabra SK; Seth V
    Indian Pediatr; 1999 Jan; 36(1):51-63. PubMed ID: 10709123
    [No Abstract]   [Full Text] [Related]  

  • 52. Clinical trials of sulfonated immunoglobulin preparation for intravenous administration. II. Adverse reactions.
    Matsumoto S; Kobayashi N; Gohya N
    Eur J Pediatr; 1981 May; 136(2):167-71. PubMed ID: 6164555
    [No Abstract]   [Full Text] [Related]  

  • 53. Established and new uses of intravenous immunoglobulin.
    Cunningham-Rundles C
    Mt Sinai J Med; 1992 Sep; 59(4):335-40. PubMed ID: 1406751
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Subcutaneous immunoglobulin replacement therapy: the European experience.
    Chapel H; Gardulf A
    Curr Opin Allergy Clin Immunol; 2013 Dec; 13(6):623-9. PubMed ID: 24126615
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term remission after allogeneic hematopoietic stem cell transplantation in LPS-responsive beige-like anchor (LRBA) deficiency.
    Seidel MG; Hirschmugl T; Gamez-Diaz L; Schwinger W; Serwas N; Deutschmann A; Gorkiewicz G; Zenz W; Windpassinger C; Grimbacher B; Urban C; Boztug K
    J Allergy Clin Immunol; 2015 May; 135(5):1384-90.e1-8. PubMed ID: 25539626
    [No Abstract]   [Full Text] [Related]  

  • 56. Europe immunoglobulin map.
    Šedivá A; Chapel H; Gardulf A;
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):141-3. PubMed ID: 25546797
    [No Abstract]   [Full Text] [Related]  

  • 57. Flebogamma(®) 5 % DIF Intravenous Immunoglobulin for Replacement Therapy in Children with Primary Immunodeficiency Diseases.
    Ballow M; Pinciaro PJ; Craig T; Kleiner G; Moy J; Ochs HD; Sleasman J; Smits W
    J Clin Immunol; 2016 Aug; 36(6):583-9. PubMed ID: 27279130
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Consensus on IVIG.
    Lancet; 1990 Aug; 336(8713):470-2. PubMed ID: 1974993
    [No Abstract]   [Full Text] [Related]  

  • 59. Reversible Hypogammaglobulinemia in 2 Pediatric Patients With Primary Immunodeficiency.
    Pasic S
    J Investig Allergol Clin Immunol; 2017; 27(5):320-321. PubMed ID: 29057740
    [No Abstract]   [Full Text] [Related]  

  • 60. [Use of IVIG in secondary immunodeficiencies].
    Zeman K; Lewandowicz-Uszyńska A
    Postepy Hig Med Dosw; 2002; 56 Suppl():91-102. PubMed ID: 12661419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.